Top Markets
Coin of the day
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
株式のランク #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
株価
$0.2301
最終同期: 2026-08-12
時価総額
$228.81K
変化(1日)
-17.82%
変化(1年)
95,775.00%
US
取引 The Greater Cannabis Company, Inc. (GCAN)

カテゴリー

The Greater Cannabis Company, Inc.(GCAN)の配当利回りの履歴
The Greater Cannabis Company, Inc.(銘柄コード: GCAN)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
The Greater Cannabis Company, Inc.(GCAN)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)